UPM-Kymmene Oyj
XBER:RPL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
UPM-Kymmene Oyj
XBER:RPL
|
FI |
|
A
|
AstraZeneca PLC
STO:AZN
|
UK |
|
Plant Health Care PLC
LSE:PHC
|
US |
|
T
|
Teradyne Inc
LSE:0LEF
|
US |
|
FirstEnergy Corp
NYSE:FE
|
US |
|
A
|
Auction Mills Inc
OTC:AUNM
|
US |
|
M
|
Mitek Systems Inc
SWB:MKQ
|
US |
|
S
|
Siauliu Bankas AB
SWB:ZH5
|
LT |
|
C
|
China Petroleum & Chemical Corp
DUS:CHU
|
CN |
|
N
|
National Bank of Canada
OTC:NTIOF
|
CA |
|
F
|
Flutter Entertainment PLC
ISEQ:FLTR
|
IE |
|
B
|
Baytex Energy Corp
F:B5X
|
CA |
|
Mitsuba Corp
TSE:7280
|
JP |
Wall St Price Targets
RPL Price Targets Summary
UPM-Kymmene Oyj
According to Wall Street analysts, the average 1-year price target for RPL is 26.4 EUR with a low forecast of 20.4 EUR and a high forecast of 32.31 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RPL's stock price target?
Price Target
26.4
EUR
According to Wall Street analysts, the average 1-year price target for RPL is 26.4 EUR with a low forecast of 20.4 EUR and a high forecast of 32.31 EUR.
What is the Revenue forecast for UPM-Kymmene Oyj?
Projected CAGR
1%
Over the last 14 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 1%.
What is the Operating Income forecast for UPM-Kymmene Oyj?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 8 years is 13%.
What is the Net Income forecast for UPM-Kymmene Oyj?
Projected CAGR
25%
Over the last 14 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 4 years is 25%.
